Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-02-21
1999-10-05
Campbell, Bruce R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
424 9321, 4243201, 424 691, 424455, 424458, 536 241, A01N 4304
Patent
active
059624248
ABSTRACT:
Disclosed are a variety of compositions and methods for use in specifically targeting the L-selectin or preferably, the E-selectin marker following its cell surface induction, e.g., using ionizing radiation, in tumor vasculature endothelial cells. The compositions and methods described are suitable for use in the delivery of selected agents to tumor vasculature, as may be used in the diagnosis aid therapy of solid tumors.
REFERENCES:
Mastrangelo et al., J Seminars in Oncology, vol. 23, 1:4-21, 1996.
Ledley, Human Gene Therapy, 6:1129-1144, 1995.
Gunzburg et al., Molecular Medicine Today, 1995, 410-417, 1995.
Weichselbaum et al, Int. J. Radiation Oncology, 24:565-567 (1992).
Cameron et al., J. Exp. Medicine, 171:249-263 (1990).
Salmi et al., J. Immunology, 154:6002-6012 (1995).
Abbassi et al., "E-Selectin Supports Neutrophil Rolling In Vitro Under Conditions of Flow," J. Clin. Invest., 92:2719-2730, Dec. 1993.
Bicknell, "Vascular Targeting and the Inhibition of Angiogenesis," Annals. of Oncology, 5(Suppl. 4):S45-S50, 1994.
Cavenagh et al., "Acute Myeloid Leukaemia Blast Cells Bind to Human Endothelium In Vitro Utilizing E-Selectin and Vascular Cell Adhesion Molecule-1 (VCAM-1)," British Journal of Haematology, 85:285-291, 1993.
Chapman et al., "Noninvasive Imaging of E-Selectin Expression by Activated Endothelium in Urate Crystal-Induced Arthritis," Arthritis & Rheumatism, 37(12):1752-1756, Dec. 1994.
Collins, "Biology of Disease, Endothelial Nuclear Factor-.kappa.B and The Initiation of the Atherosclerotic Lesion," Laboratory Investigation, 68(5):499, 1993.
De Boer et al., "Functional Evidence that the HECA-452 Antigen is Involved in the Adhesion of Human Neutrophils and Lymphocytes to Tumour Necrosis Factor-.alpha.-Stimulated Endothelial Cells," Immunology, 81:359-365, 1994.
Finco and Baldwin, ".kappa.B Site-Dependent Induction of Gene Expression by Diverse Inducers of Nuclear Factor .kappa.B Requires Raf-1," The Journal of Biological Chemistry, 268(24):17676-17679, Aug. 1993.
Ghersa et al., "Labile Proteins Play a Dual Role in the Control of Endothelial Leukocyte Adhesion Molecule-1 (ELAM-1) Gene Regulation," The Journal of Biological Chemistry, 267(27):19226-19232, Sep. 1992.
Goelz et al., "Differential Expression of an E-Selectin Ligand (SLe.sup.x) by Two Chinese Hamster Ovary Cell Lines Transfected with the Same .alpha.(1,3)-Fucosyltransferase Gene (ELFT)," The Journal of Biological Chemistry, 269(2):1033-1040, Jan. 1994.
Gosset et al., "Expression of E-Selectin, ICAM-1 and VCAM-1 on Bronchial Biopsies from Allergic and Non-Allergic Asthmatic Patients," Int. Arch. Allergy Immunol., 106:69-77, 1995.
Green et al., "High Affinity Binding of the Leucocyte Adhesion Molecule L-Selectin to 3'-Sulphated-Le.sup.a and -Le.sup.x Oligosaccharides and the Predominance of Sulphate in this Interaction Demonstrated by Binding Studies with a Series of Lipid-Linked Oligosaccharides," Biochemical and Biophysical Research Communications, 188(1):244-251, Oct. 1992.
Grinnell et al., "Human Protein C inhibits selectin-mediated cell adhesion: role of unique fucosylated oligosaccharide," Glycobiology, 4(2):221-225, 1994.
Groves et al., "Endothelial Leucocyte Adhesion Molecule-1 (ELAM-1) Expression in Cutaneous Inflammation," British Journal of Dermatology, 124:117-123, 1991.
Hallahan et al., "Increased Tumor Necrosis Factor .alpha. mRNA After Cellular Exposure to Ionizing Radiation," Proc. Natl. Acad. Sci. USA, 86:10104-10107, Dec. 1989.
Hallahan et al., "Transcriptional Regulation of the TNF Gene by x-Irradiation," Proc. Am. Assoc. Cancer Res., 31(0):75, Mar. 1990.
Hallahan et al., "Tumor Necrosis Factor Gene Expression is Mediated by Protein Kinase C Following Activation by Ionizing Radiation," Cancer Research, 51:4565-4569, Sep. 1991.
Hallahan et al., "Radiation Signaling Mediated by Jun Activation Following Dissociation from a Cell Type-Specific Repressor," The Journal of Biological Chemistry, 268(7):4903-4907, Mar. 1993.
Hallahan et al., "The Role of Cytokines in Radiation Oncology," Important Advances in Oncology, 1993.
Hallahan et al., "Membrane-Derived Second Messenger Regulates X-Ray-Mediated Tumor Necrosis Factor .alpha. Gene Induction," Proc. Natl. Acad. Sci. USA, 91:4897-4901, May 1994.
Harris et al., "Gene Therapy Through Signal Transduction Pathways and Angiogenic Growth Factors as Therapeutic Targets in Breast Cancer," Cancer Supplement, 74(3):1021-1025, Aug. 1994.
Hasegawa et al., "Synthesis of Deoxy-L-Fucose-Containing Sialyl Lewis X Ganglioside Analogues," Carbohydrate Research, 257:67-80, 1994.
Hwu et al., "Functional and Molecular Characterization of Tumor-Infiltrating Lymphocytes Transduced with Tumor Necrosis Factor-.alpha. cDNA for the Gene Therapy of Cancer in Humans," The Journal of Immunology, 150(9):4104-4115, May 1993.
Jutila et al., "Characterization of a Functionally Important and Evolutionarily Well-Conserved Epitope Mapped to the Short Consensus Repeats of E-Selectin and L-Selectin," J. Exp. Med., 175:1565-1573, Jun. 1992.
Keelan et al., "Characterization of E-Selectin Expression In Vivo with Use of a Radiolabeled Monoclonal Antibody," Am. J. Physiol., 266(1 Pt 2):H279-H290, Jan. 1994.
Keelan et al., "Imaging Vascular Endothelial Activation: An Approach Using Radiolabeled Monoclonal Antibodies Against the Endothelial Cell Adhesion Molecule E-Selectin," The Journal of Nuclear Medicine, 35(2):276-281, Feb. 1994.
Kojima et al., "Multi-Recognition Capability of E-Selectin in a Dynamic Flow System, as Evidenced by Differential Effects of Sialidases and Anti-Carbohydrate Antibodies on Selectin-Mediated Cell Adhesion at Low vs. High Wall Shear Stress: A Preliminary Note," Biochemical and Biophysical Research Communications, 189(3):1686-1694, Dec. 1992.
Lo et al., "E-Selectin Ligands Mediate Tumor Necrosis Factor-Induced Neutrophil Sequestration and Pulmonary Edema in Guinea Pig Lungs," Circulation Research, 75(6):955-960, Dec. 1994.
Montefort et al., "Intercellular Adhesion Molecule-1 (ICAM-1) and Endothelial Leucocyte Adhesion Molecule-1 (ELAM-1) Expression int he Bronchial Mucosa of Normal and Asthmatic Subjects," Eur. Respir. J., 5:815-823, 1992.
Montgomery et al., "Activation of Endothelial-Leukocyte Adhesion Molecule 1 (ELAM-1) Gene Transcription," Proc. natl. Acad. Sci. USA, 88:6523-6527, Aug. 1991.
Moughal et al., Endothelial Cell Leukocyte Adhesion Molecule-1 (ELMA-1) and Intercellular Adhesion Molecule-1 (ICAM-1) Expression in Gingival Tissue During Health and Experimentally-Induced Gingivitis, J. Periodont. Res., 27:623-630, 1992.
Mulligan et al., "Protective Effects of Sialylated Oligosaccharides in Immune Complex-Induced Acute Lung Injury," J. Exp. Med., 178:623-631, Aug. 1993.
Nabel et al., "Gene Transfer and Vascular Disease," Cardiovascular Research, 28:445-455, 1994.
Rao et al., "Sialyl Lewis X Mimics Derived from a Pharmacophore Search are Selectin Inhibitors with Anti-inflammatory Activity," The Journal of Biological Chemistry, 269(31):19663-19666, Aug. 1994.
Nelson et al., "Higher-Affinity Oligosaccharide Ligands for E-Selectin," J. Clin. Invest., 91:1157-1166, Mar. 1993.
Neumann et al., "Immunohistochemistry of Port-Wine Stains and Normal Skin with Endothelium-Specific Antibodies PAL-E, Anti-ICAM-1, Anti-ELAM-1, and Anti-Factor VIIIrAg," Arch Dermatol., 130:879-883, Jul. 1994.
Norton et al., "Characterization of Murine E-Selectin Expression In Vitro Using Novel Anti-Mouse E-Selectin Monoclonal Antibodies," Biochemical and Biophysical Research Communications, 195(1):250-258, Aug. 1993.
Ohno et al., "Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial Injury," Science, 265:781-784, Aug. 1994.
Olofsson et al., "E-Selectin Mediates Leukocyte Rolling in Interleukin-1-Treated Rabbit Mesentery Venules," Blood, 84(8):2749-2758, Oct. 1994.
Pai et al., "Antitumor Effects of B3-PE and B3-LysPE40 in a Nude Mouse Model of Human Breast Cancer and the Evaluation of B3-PE Toxicity in Monkeys," Cancer Research, 52:3189-3193, Jun. 1992.
Phillips et al., "ELAM-1 Mediates Cell Adhesion by Recognition of a Carbohydrate Ligand, Sialyl-Le.sup.x," Scien
Hallahan Dennis E.
Weichselbaum Ralph R.
ARCH Development Corporation
Campbell Bruce R.
Nguyen Dave Trong
LandOfFree
Methods and compositions for targeting selectins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for targeting selectins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for targeting selectins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1171492